Marketing - Press Releases

Date	Title	Company
20-Jul-2020	Sanifit to start new clinical development program of SNF472 in End Stage Kidney Disease patients with Peripheral Artery Disease	Sanifit
20-Jul-2020	PTC Therapeutics Announces Agreement to Monetize a Portion of the Risdiplam Royalty Stream for $650 Million	PTC Therapeutics, Inc.
17-Jul-2020	Verona Pharma Raises $200 Million in Oversubscribed Private Placement and Subscription	Verona Pharma plc
17-Jul-2020	RedHill Biopharma Receives Approval for Phase 2/3 COVID-19 Study in Russia	RedHill Biopharma Ltd
17-Jul-2020	Celltrion launches human clinical trial of potential COVID-19 antiviral antibody treatment following positive pre-clinical results	Celltrion Healthcare
17-Jul-2020	Eli Lilly’s and Regeneron’s COVID-19 mAbs spark interest as monotherapies along with potential as cocktails for treatment and postexposure prevention, says GlobalData	GlobalData
17-Jul-2020	Tiziana Announces Submission of Patent Application on Use of Foralumab, the Only Fully Human Anti-CD3 Monoclonal Antibody, to Enhance Success of CAR-T Therapy	Tiziana Life Sciences plc
17-Jul-2020	Tiziana Life Sciences plc Change to ADS Ratio - Updated	Tiziana Life Sciences plc
15-Jul-2020	Macomics, an immuno-oncology company, secures £3.2 million seed funding from Epidarex Capital & the Scottish Investment Bank	Macomics Ltd
15-Jul-2020	CARDIOVASCULAR MEDTECH SECTOR TO ENJOY STRONG GROWTH BUT IT NEEDS A BIGGER FOCUS ON DATA AND REAL-WORLD EVIDENCE	Zegami
15-Jul-2020	Transgene and Hypertrust Patient Data Care announce successful go-live of the world’s first blockchain solution for clinical trials of personalized healthcare	Transgene and Hypertrust Patient
15-Jul-2020	Sermonix Pharmaceuticals to Collaborate With Eli Lilly and Company in Studying Combination of Lasofoxifene and Lilly’s CDK 4 and 6 Inhibitor, Abemaciclib, in Metastatic Breast Cancer	Sermonix Pharmaceuticals Inc
15-Jul-2020	INTELLEGENS AWARDED FUNDING BY INNOVATE UK TO MODEL COVID-19 DATA AND IMPROVE PANDEMIC MANAGEMENT	Intellegens
15-Jul-2020	Koura announces major investment into new ‘greener’ medical propellant production facility in United Kingdom	Koura
15-Jul-2020	Sosei Heptares notes Enerzair® Breezhaler® approval in the European Union as a treatment for uncontrolled asthma	Sosei Group Corporation
15-Jul-2020	Novartis receives EC approval for Enerzair® Breezhaler®, including the first digital companion (sensor and app) that can be prescribed alongside a treatment for uncontrolled asthma in the EU	Novartis
15-Jul-2020	Rates of bleeding and venous thromboembolism (VTE) events reported after 12 months of edoxaban ▼ treatment considered low by real-world ETNA-VTE study investigators	Daiichi Sankyo
15-Jul-2020	Acacia Pharma Assigned US License for BYFAVO™ (remimazolam) by Cosmo Pharmaceuticals NV	Acacia Pharma
15-Jul-2020	Bridge Biotherapeutics becomes BaseLaunch’s first Asia Pacific partner	BaseLaunch
15-Jul-2020	J&J's price reduction of lifesaving TB drug is an important step; governments must scale up use	Johnson & Johnson